Thousands of Premier Members to Have Access to Preferred Pricing for VolparaDensity and Volpara’s Full Suite of Quantitative Breast Imaging Tools
WELLINGTON, New Zealand, October 1, 2015 – Volpara Solutions, the leading provider of volumetric breast density and quantitative breast imaging tools, announced today the execution of a group purchasing agreement with Premier, Inc., an alliance of more than 3,600 U.S. hospitals and 120,000-plus other healthcare sites working together to achieve high quality, cost-effective care. The three-year agreement extends Premier members preferred pricing on VolparaDensity and the company’s full suite of quantitative breast imaging tools. Volpara Solutions technology is currently in use in 31 countries and more than 7-million women have had their breast density analyzed using VolparaDensity.
“Over the years, Premier has shown tremendous commitment to improving access to advances in women’s healthcare and we are pleased to work with them to make Volpara’s volumetric breast density assessment and quantitative breast imaging software tools immediately available to Premier members,” said Ralph Highnam, Ph.D., CEO, Volpara Solutions. “With extensive scientific validation and broad clinical use, VolparaDensity gives users a powerful tool to consistently provide accurate breast density information to help improve breast screening, particularly for women with dense breasts.”
Cleared by the FDA, HealthCanada, the TGA and CE-marked, VolparaDensity is in use at breast imaging centers worldwide to help radiologists objectively assess density from digital mammography images to help doctors evaluate who might benefit from additional screening. Highly correlated to breast MR assessments, VolparaDensity is a reliable tool that automatically generates an objective measurement of volumetric breast density correlated to the ACR (American College of Radiology) breast density categories. VolparaDensity is part of a suite of quantitative breast imaging tools built on the Volpara Solutions algorithm that allows for personalized measurements of density, patient dose, breast compression and other factors designed to help maintain accuracy and consistent quality in breast screening.
VolparaDensity was recently named a semi-finalist for Best New Radiology Software in 2015 edition of the Minnies, AuntMinnie.com’s campaign to recognize the best and brightest in medical imaging.
About Premier, Inc.
Premier, Inc. (NASDAQ: PINC) is a leading healthcare improvement company, uniting an alliance of approximately 3,600 U.S. hospitals and 120,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost. Premier, a Malcolm Baldrige National Quality Award recipient, plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier’s news and investor sites on www.premierinc.com; as well as Twitter, Facebook, LinkedIn, YouTube, Instagram and Premier’s blog for more information about the company.
About Volpara Solutions
Founded with the goal of helping radiologists give women the most accurate information possible regarding their breast health, Volpara Solutions is the wholly owned sales and marketing arm of Volpara Health Technologies Limited of New Zealand. Cleared by the FDA, HealthCanada, the TGA, and CE-marked, VolparaDensity provides an objective volumetric measure of breast density from digital mammography. VolparaDensity is part of a suite of quantitative breast imaging tools built on the Volpara Solutions algorithm that allows for personalized measurements of density, patient-specific x-ray dose, breast compression and other factors designed to provide critical insight for breast imaging workflow.
